Una guía para su detección y manejo clínico | 05 JUN 17
El intervalo QT durante el tratamiento con fármacos
El intervalo QT es una parte clave del ECG de superficie, y cuando se prolonga se asocia con arritmias potencialmente fatales. Diversos síndromes hereditarios y fármacos pueden producirlo
Autor/a: dtbeditor@bmjgroup.com QT interval and drug therapy
Página 1
- Moss AJ. The QT interval and torsade de pointes. Drug Saf1999;21(Suppl 1):5-10, discussion 81-7. doi:10.2165/00002018-199921001-00002 pmid:10597863.
- Isbister GK, Page CB. Drug induced QT prolongation: the measurement and assessment of the QT interval in clinical practice. Br J Clin Pharmacol2013;76:48-57. doi:10.1111/bcp.12040 pmid:23167578.
- Nachimuthu S, Assar MD, Schussler JM. Drug-induced QT interval prolongation: mechanisms and clinical management. Ther Adv Drug Saf2012;3:241-53. doi:10.1177/2042098612454283 pmid:25083239.
- Surawicz B, Gettes LS, et al. American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology American College of Cardiology Foundation Heart Rhythm Society Endorsed by the International Society for Computerized Electrocardiology. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. J Am Coll Cardiol2009;53:982-91. doi:10.1016/j.jacc.2008.12.014 pmid:19281931.
- Yang T, Snyders D, Roden DM. Drug block of I(kr): model systems and relevance to human arrhythmias. J Cardiovasc Pharmacol2001;38:737-44. doi:10.1097/00005344-200111000-00010 pmid:11602820.
- Drew BJ, Ackerman MJ, Funk M, et al. American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology, the Council on Cardiovascular Nursing, and the American College of Cardiology Foundation. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. Circulation2010;121:1047-60. doi:10.1161/CIRCULATIONAHA.109.192704 pmid:20142454.
- Trinkley KE, Page RL IInd, , Lien H, Yamanouye K, Tisdale JE. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians. Curr Med Res Opin2013;29:1719-26. doi:10.1185/03007995.2013.840568 pmid:24020938.
- Moss AJ, Schwartz PJ, Crampton RS, et al. The long QT syndrome. Prospective longitudinal study of 328 families. Circulation1991;84:1136-44. doi:10.1161/01.CIR.84.3.1136 pmid:1884444.
- Schwartz PJ, Crotti L, Insolia R. Long-QT syndrome: from genetics to management. Circ Arrhythm Electrophysiol2012;5:868-77. doi:10.1161/CIRCEP.111.962019 pmid:22895603.
- Schwartz PJ, Ackerman MJ. The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy. Eur Heart J2013;34:3109-16. doi:10.1093/eurheartj/eht089 pmid:23509228.
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024